Transce3nd’s Hologic HOLX Stock Holding History

Transce3nd’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,333	Closed	-$96.1K	–	1356
2024 Q4	$96.1K	Buy	+1,333	New	+$104K	0.03%	264

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Transce3nd's HOLX Position: Q1 2025 in Review

Transce3nd sold out of Hologic (HOLX) in Q1 2025, closing a stake of 1,333 shares — an estimated $96.1K sold.

Transce3nd first reported a position in HOLX in Q4 2024 and held it in 1 quarter. The position peaked at $96.1K in Q4 2024. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

Transce3nd reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 1,333 Hologic shares in Q1 2025, an estimated $96.1K.
Transce3nd first reported a position in Hologic in Q4 2024 and held it in 1 quarter.
Transce3nd's Hologic position peaked at $96.1K in Q4 2024.
706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.